SQZ Biotech Expands Leadership Team, Appoints Shefali Agarwal, MD, MPH, as Chief Medical Officer SQZ Biotech (SQZ), a preclinical stage biotechnology company developing cell therapies based on its proprietary CellSqueeze® technology, announced today the appointment of Shefali Agarwal, MD, … Continued
It sounds futuristic, but it’s not sci-fi: Human organs-on-a-chip There is an emerging biotech movement that promises to transform medical science and radically overhaul the arduous process of bringing new drugs, foods and cosmetics to market. Teams of academic … Continued
Crocus Technology, a leading developer of an MLU™ based TMR magnetic sensor technology and embedded MRAM, today announced the release of its 2nd generation Digital Magnetic Latch, the CT83x series. In response to a market gravitating towards high sensitivity, low … Continued
ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced the appointment of Naiyer A. Rizvi, M.D. to its Board of Directors. Dr. Rizvi is the Director of Thoracic Oncology and Co-Director of Cancer Immunotherapy in the Division of Hematology and Oncology at Columbia University … Continued
View Completes over $200M financing round with $70M investment from BlackRock View®, the leader in dynamic glass, today announced that it has completed a financing round of over $200M, including a $70 million investment from funds and accounts managed … Continued
Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune responses, today announced that it has entered into definitive agreements to sell securities in a private placement that is expected … Continued
Emulate, Inc. announced today that it has received a research grant to use the company’s human Brain-Chip system and develop a fully automated research platform, to conduct experiments on the International Space Station. Studies will analyze the Brain-Chip, which consists … Continued
Tarveda Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing Pentarins™ as a new class of potent and selective cancer medicines, today announced the appointment of Michael A. Metzger to the company’s Board of Directors. Mr. Metzger has more than … Continued
Selecta Biosciences, a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune responses, today announced data from its ongoing Phase 2 trial of SEL-212 (SVP-Rapamycin in combination with the uricase enzyme pegsiticase), which … Continued
Today SQZ Biotech, a pre-clinical stage biotechnology company developing cell therapies, announced it was selected as a member of the 2017 class of World Economic Forum Technology Pioneers. SQZ is one of only thirty companies selected and was recognized for … Continued